Komori
Parker (9845) · InitiativeRestated

Accounting Estimates Based on the Impact of COVID-19 and Assumed Recovery Beginning in the Second Quarter

First written in FY2021-Q1. 7 of 8 entries say "Restated". Latest entry: FY2022.

8entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q1 – FY20222020: 220202021: 420212022: 22022
Same theme, other companies
Accounting Estimates Based on Assumptions Regarding COVID-19A theme 628 companies write about · 490 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 5 of 23 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 631 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「Although we assume that the impact of COVID-19 will continue for a certain period after the current consolidated fiscal year, we expect conditions to gradually recover. Accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets, are based on this assumption.」

    The company continues to reflect the assumption of a gradual recovery in its accounting estimates, despite the impact of the infectious disease continuing for a certain period.
  2. FY2022-Q3RestatedAnnual report

    「There have been no material changes to the assumptions regarding the impact of the spread of this infectious disease described in the “Additional Information” section of the annual securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes to the assumptions underlying its accounting estimates regarding the impact of the infectious disease described in the annual securities report for the previous fiscal year.
  3. FY2022-Q2RestatedAnnual report

    「There have been no material changes to the assumptions regarding the impact of the spread of this infectious disease described in the “Additional Information” section of the annual securities report for the previous consolidated fiscal year.」

    The company states that there have been no material changes to the assumptions underlying its accounting estimates regarding the impact of the infectious disease described in the annual securities report for the previous fiscal year.
  4. FY2022-Q1RestatedAnnual report

    「We assume that the impact of this situation will continue for a certain period after the first quarter of the current consolidated fiscal year, but expect conditions to gradually recover. Accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets, are based on this assumption.」

    The company continues to reflect the assumption of a gradual recovery, despite the impact of the infectious disease continuing for a certain period, in accounting estimates including the recoverability of deferred tax assets and impairment testing of fixed assets.
  5. FY2021RestatedAnnual report

    「We assume that the impact of this situation will continue for a certain period after the current consolidated fiscal year, but expect conditions to gradually recover. Accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets, are based on this assumption.」

    While the impact of the infectious disease is expected to continue for a certain period, the company assumes a gradual recovery and continues to reflect this assumption in the recoverability of deferred tax assets and impairment testing of fixed assets.
  6. FY2021-Q3RestatedAnnual report

    「We assume that the impact of this situation will continue for a certain period after the current consolidated fiscal year, but expect conditions to gradually recover as production activities resume. Accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets, are based on this assumption.」

    While the impact of the infectious disease is expected to continue for a certain period, the company assumes a gradual recovery as production activities resume and continues to reflect this assumption in accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets.
  7. FY2021-Q2RestatedAnnual report

    「We assume that the impact of this situation will continue for a certain period after the current consolidated fiscal year, but expect conditions to gradually recover as production activities resume. Accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets, are based on this assumption.」

    While the impact of the infectious disease is expected to continue for a certain period, the company assumes a gradual recovery as production activities resume and continues to reflect this assumption in accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets.
  8. FY2021-Q1First statedAnnual report

    「Although the infectious disease is expected to continue having a broad impact on society and the economy, economic activity has gradually resumed following the lifting of the government’s state of emergency declaration. Accordingly, we assume that the economy will begin recovering from the second quarter. Accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets, are based on this assumption.」

    Assuming a recovery from the second quarter in response to the impact of COVID-19, the company has reflected this assumption in accounting estimates, including the recoverability of deferred tax assets and impairment testing of fixed assets.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Parker's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.